- Scientists Create Foldable Stem Cell Patch to Heal Heart Damage
- ByHeart Infant Formula Recalled Amid Botulism Outbreak, Investigation Continues
- Nationwide Recall Alert: ADHD Drug May Not Dissolve Correctly
- Multiple Sclerosis Explained: Symptoms, Risk Factors & How It’s Treated
- Many Teens, Young Adults Turning To AI Chatbots For Mental Health Advice
- Oral Immunotherapy Helps Many Kids Lose Food Allergies, Studies Say
- Blood Tests Might Be Able To Judge Concussion Severity
- COVID Vaccine Offers Health Boost For Kids With Eczema
- More Americans, Especially Black Adults, Dying Before They Qualify For Medicare
- Injectable, Self-Implanting Chips Offer Hope For Brain Disorders
Blood Test Might One Day Help Spot Migraines

Researchers report that measuring levels of certain fats in the bloodstream might one day help spot women at high risk for migraines.
“While more research is needed to confirm these initial findings, the possibility of discovering a new biomarker for migraine is exciting,” wrote study author Dr. B. Lee Peterlin, associate professor of neurology at Johns Hopkins University School of Medicine in Baltimore.
In the study, the researchers assessed 52 women with episodic migraine (average of nearly six migraines a month) and 36 women who did not have the debilitating headaches. Blood samples from the women were checked for fats called ceramides, which help regulate energy and brain inflammation.
Women with episodic migraines had lower levels of ceramides than those who did not have headaches. Every standard deviation increase in ceramide levels was associated with about a 92 percent lower risk of migraine.
Conversely, the researchers found that two other types of fats were associated with a 2.5 times greater risk of migraine with every standard deviation increase in their levels.
The researchers also tested the blood of a random sample of 14 of the participants and, based on these blood fat levels, correctly identified which women had migraines and which women did not.
The findings were published online Sept. 9 in the journal Neurology.
In an editorial accompanying the study, Dr. Karl Ekbom, of the Karolinska Institute in Stockholm, Sweden, wrote, “This study is a very important contribution to our understanding of the underpinnings of migraine and may have wide-ranging effects in diagnosing and treating migraine if the results are replicated in further studies.”
More information
The U.S. National Institute of Neurological Disorders and Stroke has more about migraine.
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.


-120x134.jpg)







